MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

07 Feb 2026 Evaluate
The Revenue for the quarter ended  December 2025 of Rs. 3738.60 millions grew by 20.69 % from Rs. 3097.70 millions.A slender decline of -14.64% was recorded to Rs. 775.90  millions from Rs. 909.00 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 1148.20 millions from 1273.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202406 202306 % Var
Sales 3738.60 3097.70 20.69 19716.90 17744.40 11.12 11512.60 12296.20 -6.37
Other Income 43.60 39.60 10.10 236.90 228.70 3.59 156.30 183.90 -15.01
PBIDT 1148.20 1273.90 -9.87 6631.50 5663.40 17.09 3216.30 3430.70 -6.25
Interest 1.00 1.50 -33.33 7.70 10.20 -24.51 7.20 7.70 -6.49
PBDT 1147.20 1272.40 -9.84 6623.80 5451.30 21.51 3007.20 3423.00 -12.15
Depreciation 59.00 55.50 6.31 341.10 387.20 -11.91 274.00 281.00 -2.49
PBT 1088.20 1216.90 -10.58 6282.70 5064.10 24.06 2733.20 3142.00 -13.01
TAX 312.30 307.90 1.43 1615.50 1322.00 22.20 723.40 847.30 -14.62
Deferred Tax -16.70 17.50 -195.43 -25.30 -57.30 -55.85 -86.00 -50.60 69.96
PAT 775.90 909.00 -14.64 4667.20 3742.10 24.72 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 30.71 41.12 -25.32 33.63 31.92 5.38 27.94 27.90 0.13
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..